UPDATE: Morgan Stanley Starts Karyopharm Therapeutics (KPTI) at Overweight Using Xpovio as a Primary Catalyst
Go back to UPDATE: Morgan Stanley Starts Karyopharm Therapeutics (KPTI) at Overweight Using Xpovio as a Primary Catalyst| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.06 -0.03 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $19.41 | |||
| Open | $1.07 | 52 Week Low | $4.83 | |||
| Day High | $1.10 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $-2.74 | |||
| Volume | 644,718 | |||||
